Agomelatine (Valdoxan) in Treatment of Endogenous Depression in Day Patient Department

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova - Russian Federation
doi 10.17116/jnevro201611610143-46
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

Defense Mechanisms in Endogenous Depression

Gulhane Medical Journal
Medicine
2014English

Endogenous Depression in General Practice

BMJ
1947English

Diagnosis of Endogenous Depression

Journal of Affective Disorders
PsychiatryClinical PsychologyMental Health
1980English

Mild Endogenous Depression

BMJ
1957English

Agomelatine in the Treatment of Depressive Disorders in Clinical Practice: Multicenter Observational CHRONOS Study

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2014English

Improvement in Fatigue During Natalizumab Treatment Is Linked to Improvement in Depression and Day-Time Sleepiness

Frontiers in Neurology
Neurology
2015English

Pmh73 - The Burden of Treatment-Resistant Depression in Europe From the Patient Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Osteopathic Manipulative Treatment Applications for the Emergency Department Patient

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1996English

Mining of Patient Data: Towards Better Treatment Strategies for Depression

International Journal of Functional Informatics and Personalised Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy